The association of serum androsterone glucuronide with inflammatory lesions in women with adult acne

Journal of Endocrinological Investigation

Volumn 25, Issue 9, 2002, Pages 765-768

  Carmina, E ^a,d   Godwin, A J ^b   Stanczyk, F Z ^c   Lippman, J S ^a   Lobo, Rogerio A ^a,d  

^a UNIVERSITY OF PALERMO   (Italy)

^b ETHICON INC   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d Columbia Univrsity College of Physicians and Surgeons ^*  (United States)

Author keywords

Acne; Androsterone glucuronide; Hyperandrogenism

Indexed keywords

ANDROGEN; ANDROSTERONE GLUCURONIDE; ETHINYLESTRADIOL PLUS NORGESTIMATE; HORMONE PRECURSOR; ORAL CONTRACEPTIVE AGENT; PLACEBO; PRASTERONE SULFATE; STEROID 5ALPHA REDUCTASE; TESTOSTERONE; THYROXINE; UNCLASSIFIED DRUG;

ACNE; ADOLESCENT; ADULT; ANDROGEN BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE MARKER; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; ENZYME ACTIVITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; METABOLITE; RANDOMIZED CONTROLLED TRIAL; SKIN INFLAMMATION; TESTOSTERONE BLOOD LEVEL; THYROXINE BLOOD LEVEL;

ACNE VULGARIS; ADOLESCENT; ADULT; ANDROSTERONE; BIOLOGICAL MARKERS; CONTRACEPTIVES, ORAL, COMBINED; DEHYDROEPIANDROSTERONE SULFATE; ETHINYL ESTRADIOL; FEMALE; HUMANS; INFLAMMATION; MIDDLE AGED; NORGESTREL; SKIN; TESTOSTERONE;

EID: 0036796222     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03345509     Document Type: Article

References (18)

1. Carmina E., Lobo R.A. Hirsutism, alopecia and acne. In: Becker K.L. (Ed.), Principles and Practice of Endocrinology and Metabolism. Lippincott Co. Pub., 3rd edition, Philadelphia, 2001, p. 991.
2. Lucky A.W., McGuire J., Rosenfield R.L., Lucky P.A., Rich B.H. Plasma androgens in women with acne vulgaris. J. Invest. Dermatol. 1983, 81: 70-74.
3. Hammerstein J., Moltz L., Schwartz U. Antiandrogens in the treatment of acne and hirsutism. J. Steroid Biochem. 1983, 19: 591-597.
4. Lemay A., Dewailly D., Grenier R., Huard J. Attenuation of mild hyperandrogenic activity in postpubertal acne by a triphasic oral contraceptive containing low doses of ethinylestradiol and l-norgestrel. J. Clin. Endocrinol. Metab. 1990, 71: 8-14.
5. Lookingbill D.P., Horton R., Demers L.M. Egan N., Marks J.G., Santen R.J. Tissue production of androgens in women with acne. J. Am. Acad. Dermatol. 1985, 12: 481-487.
6. Thiboutot D., Harris G., Iles V., Cimis G., Gilliland K., Hagari S. Activity of the type 1 5-alpha-reductase exhibits regional differences in isolated sebaceouse glands and whole skin. J. Invest. Dermatol. 1995, 94: 279-283.
7. Marynik S.P., Chakmakjian Z.H., McCaffree D.L., Herndon J.H. Androgen excess in cystic acne. N. Engl. J. Med. 1983, 308: 981-986.
8. Vexiau P., Husson C., Chivot M., Breault J.L. Androgen excess in women with acne alone compared with women with acne and/or hirsutism. J. Invest. Dermatol. 1990, 94: 279-283.
9. Carmina E., Stanczyk F.Z., Matteri R.K. Lobo R.A. Serum androsterone conjugates differentiate between acne and hirsutism in hyperandrogenic women. Fertil. Steril. 1991, 55: 871-876.
10. Slayden S.M. Moran C., Sams W.M., Boots L.R., Azziz R. Hyperandrogenemia in patients presenting with acne. Fertil. Steril. 2001, 75: 889-892.
11. Carmina E., Lobo R.A. Evidence for increased androsterone metabolism in some normoandrogenic women with acne. J. Clin. Endocrinol. Metab. 1993, 76: 1111-1114.
12. Carmina E., Gentzschein E., Stanczyk F.Z., Lobo R.A. Substrate dependency of C19 conjugates in hirsute hyperandrogenic women and the influence of adrenal androgen. Hum. Reprod. 1995, 10: 299-303.
13. Redmond G.P., Olson W.H., Lippman JS., Kafrissen M.E., Jones T.M., Jorizzo J.L. Norgestimate and ethinyl estradiol in the treatment of acne vulgaris: A randomized, placebo-controlled trial. Obstet. Gynecol. 1997, 89: 615-622.
14. Lucky A.W., Henderson T.A. Olson W.H., Robisch D.M., Lebwohl M., Swinyer L.J. Effectiveness of norgestimate and ethinyl estradiol in treating moderate acne vulgaris. J. Am. Acad. Dermatol. 1997, 37: 746-754.
15. Aydinlik S., Lachnit-Fixson U., Lehnert J. Reduced estrogen ovulation inhibitor in acne therapy: Double-blind study comparing Diane-35 to Diane. Fortschr. Med. 1986, 104: 547-550.
16. Carmina E., Ferin M., Lobo R.A. Evidence that insulin and androgens may participate in the regulation of serum leptin levels in women. Fertil. Steril. 1999, 72: 426-431.
17. Matteri R.K., Stanczyk F.Z., Gentzschein E.E., Delgado C., Lobo R.A. Androgen sulphate and glucuronide conjugates in non-hirsute and hirsute women with polycystic ovary syndrome. Am. J. Obstet. Gynecol. 1989, 161: 1704-1709.
18. Carmina E. A risk-benefit assessment of pharmacological therapies for hirsutism. Drug Saf. 2001, 24: 267-276.